These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2613036

  • 1. [A new test system for evaluating the risk of thromboembolism in the use of hormonal contraceptives].
    Pechlaner C, Kunz F, Tabarelli M, Sölder E, Zwierzina WD, Reitsamer R, Koch R.
    Gynakol Rundsch; 1989; 29 Suppl 2():312-4. PubMed ID: 2613036
    [No Abstract] [Full Text] [Related]

  • 2. [Oral contraceptives and thromboembolism (author's transl)].
    Sato K, Ogino M, Nakabayashi M, Sakamoto S.
    Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N, Porcelli A, Petrelli P, Amedeo M, Crivello T, Ferraris G.
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract] [Full Text] [Related]

  • 4. Oral contraceptives and hypercoagulation.
    Petitti DB.
    Clin Adv Hematol Oncol; 2006 Nov; 4(11):813-5. PubMed ID: 17143250
    [No Abstract] [Full Text] [Related]

  • 5. [19-year-old patient with thromboembolism caused by oral contraception].
    Pihusch R, de Coutre P, Salat C, Göhring P, Poley S, Hiller E.
    Internist (Berl); 1996 Nov; 37(11):1163-6. PubMed ID: 9036113
    [No Abstract] [Full Text] [Related]

  • 6. [Blood coagulation tests and oral contraceptives].
    Scalettaris U, Bertolini C, Michelon C.
    Minerva Ginecol; 1987 May; 39(5):325-7. PubMed ID: 3627540
    [No Abstract] [Full Text] [Related]

  • 7. [Hormones and hemostasis].
    Winkler UH.
    Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):M39-42. PubMed ID: 8188004
    [No Abstract] [Full Text] [Related]

  • 8. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN, Slawson JG.
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract] [Full Text] [Related]

  • 9. Oral contraceptives and venous thromboembolism.
    Savage RL.
    N Z Med J; 1997 Mar 28; 110(1040):109. PubMed ID: 9137318
    [No Abstract] [Full Text] [Related]

  • 10. [Proper education for the patient! Risk of thromboembolism with oral contraception].
    Wenderlein JM.
    MMW Fortschr Med; 2000 Feb 17; 142(7):38-9. PubMed ID: 10832333
    [No Abstract] [Full Text] [Related]

  • 11. Effects of oestro-progestogenic oral contraceptives on blood coagulation, fibrinolysis, and platelet aggregation.
    Ghezzo F, Mele A, Pegoraro L.
    Haematologica; 1980 Dec 17; 65(6):737-45. PubMed ID: 6790364
    [No Abstract] [Full Text] [Related]

  • 12. Family history and risk of venous thromboembolism with oral contraception. Family history is important tool.
    Vandenbroucke JP, van der M eer FJ, Helmerhorst FM, Rosendaal FR.
    BMJ; 2001 Sep 29; 323(7315):752. PubMed ID: 11675729
    [No Abstract] [Full Text] [Related]

  • 13. [Is it really necessary to discontinue hormonal contraceptives before carrying out a planned operation?].
    Zentralbl Gynakol; 1989 Sep 29; 111(11):771-80. PubMed ID: 2781890
    [No Abstract] [Full Text] [Related]

  • 14. [Hormonal contraception--thromboembolic disorders and surgical risk (author's transl)].
    Göretzlehner G, Frick G, Frick U.
    Zentralbl Chir; 1976 Sep 29; 101(18):1103-11. PubMed ID: 983453
    [Abstract] [Full Text] [Related]

  • 15. [The pill and thromboembolism. 2. Pathogenesis and additional risk factors. Review of the literature].
    Herzog C, Mall-Haefeli M.
    Ther Ggw; 1979 Nov 29; 118(11):1722-44. PubMed ID: 395715
    [No Abstract] [Full Text] [Related]

  • 16. Risks of oral contraceptives.
    Roberts H, McCowan L, Roke C, Liddell H, Batcheler L, Thakurdas N, Wilson J.
    N Z Med J; 1987 Jul 08; 100(827):430-1. PubMed ID: 3452077
    [No Abstract] [Full Text] [Related]

  • 17. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H, de Moerloose P, Campana A.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1756-63. PubMed ID: 8966508
    [Abstract] [Full Text] [Related]

  • 18. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E, Keller PJ.
    Praxis (Bern 1994); 1997 Oct 01; 86(40):1543-8. PubMed ID: 9417570
    [Abstract] [Full Text] [Related]

  • 19. Venous thromboembolism in relation to oral contraceptive use.
    Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S.
    Obstet Gynecol; 1987 Jan 01; 69(1):91-5. PubMed ID: 3796927
    [Abstract] [Full Text] [Related]

  • 20. [Drug-induced disturbances of the coagulation system (author's transl)].
    Hiller E.
    MMW Munch Med Wochenschr; 1980 Aug 29; 122(35):1184-90. PubMed ID: 6780799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.